Objectively measured motor activity in schizophrenia challenges the validity of expert ratings

Psychiatry Research

Volumn 169, Issue 3, 2009, Pages 187-190

  Walther, Sebastian ^a   Koschorke, Philipp ^a   Horn, Helge ^a   Strik, Werner ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Actigraphy; Emotional withdrawal; Hallucinatory behavior; PANSS; Suspiciousness

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACTIMETRY; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENDER; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; PARANOIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MOVEMENT DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 70349232200     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.06.020     Document Type: Article

References (41)

1. Ancoli-Israel S., Clopton P., Klauber M.R., Fell R., and Mason W. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 20 (1997) 24-27
2. Andreasen N.C. Positive vs. negative schizophrenia: a critical evaluation. Schizophrenia Bulletin 11 (1985) 380-389
3. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., and Poulton R. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry 59 (2002) 449-456
4. Cannon M., and Clarke M.C. Risk for schizophrenia-broadening the concepts, pushing back the boundaries. Schizophrenia Research 79 (2005) 5-13
5. Farrow T.F., Hunter M.D., Wilkinson I.D., Green R.D., and Spence S.A. Structural brain correlates of unconstrained motor activity in people with schizophrenia. British Journal of Psychiatry 187 (2005) 481-482
6. Farrow T.F., Hunter M.D., Haque R., and Spence S.A. Modafinil and unconstrained motor activity in schizophrenia: double-blind crossover placebo-controlled trial. British Journal of Psychiatry 189 (2006) 461-462
7. Flyckt L., Sydow O., Bjerkenstedt L., Edman G., Rydin E., and Wiesel F.A. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Research 86 (1999) 113-129
8. Haug H.J., Wirz-Justice A., and Rossler W. Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patients. Acta Psychiatrica Scandinavica Supplementum (2000) 91-95
9. Helldin L., Kane J.M., Karilampi U., Norlander T., and Archer T. Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders. Schizophrenia Research 93 (2007) 160-168
10. Hofstetter J.R., Lysaker P.H., and Mayeda A.R. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry 5 (2005) 13
11. Ismail B., Cantor-Graae E., and McNeil T.F. Neurological abnormalities in schizophrenic patients and their siblings. American Journal of Psychiatry. 155 (1998) 84-89
12. Jones S.H., Hare D.J., and Evershed K. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disorders 7 (2005) 176-186
13. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
14. Kay S.R., Opler L.A., and Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Research 23 (1988) 99-110
15. Kiang M., Christensen B.K., Remington G., and Kapur S. Apathy in schizophrenia: clinical correlates and association with functional outcome. Schizophrenia Research 63 (2003) 79-88
16. Lancon C., Aghababian V., Llorca P.M., and Auquier P. Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatrica Scandinavica 98 (1998) 369-376
17. Mahlberg R., Kunz D., Sutej I., Kuhl K.P., and Hellweg R. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. Journal of Clinical Psychopharmacology 24 (2004) 456-459
18. Martin J.L., Jeste D.V., and Ancoli-Israel S. Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. Journal of Psychiatric Research 39 (2005) 251-259
19. McCreadie R.G., Srinivasan T.N., Padmavati R., and Thara R. Extrapyramidal symptoms in unmedicated schizophrenia. Journal of Psychiatric Research 39 (2005) 261-266
20. Middelkoop H.A., van Dam E.M., Smilde-van den Doel D.A., and Van Dijk G. 45-hour continuous quintuple-site actimetry: relations between trunk and limb movements and effects of circadian sleep-wake rhythmicity. Psychophysiology 34 (1997) 199-203
21. Normann C., Schmauss M., Bakri N., Gerwe M., and Schreiner A. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets. Pharmacopsychiatry 39 (2006) 209-212
22. Peralta V., and Cuesta M.J. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophrenia Research 47 (2001) 107-116
23. Pilcher J.J., Michalowski K.R., and Carrigan R.D. The prevalence of daytime napping and its relationship to nighttime sleep. Behavioral Medicine 27 (2001) 71-76
24. Poyurovsky M., Nave R., Epstein R., Tzischinsky O., Schneidman M., Barnes T.R.E., Weizman A., and Lavie P. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia. European Neuropsychopharmacology 10 (2000) 171-176
25. Putzhammer A., Heindl B., Broll K., Pfeiff L., Perfahl M., and Hajak G. Spatial and temporal parameters of gait disturbances in schizophrenic patients. Schizophrenia Research 69 (2004) 159-166
26. Putzhammer A., Perfahl M., Pfeiff L., and Hajak G. Correlations of subjective well-being with gait parameters, expert-rated motor disturbances, and psychopathological status. Pharmacopsychiatry 38 (2005) 132-138
27. Putzhammer A., Perfahl M., Pfeiff L., Ibach B., Johann M., Zitzelsberger U., and Hajak G. Performance of diadochokinetic movements in schizophrenic patients. Schizophrenia Research 79 (2005) 271-280
28. Ramaekers J.G., Louwerens J.W., Muntjewerff N.D., Milius H., de Bie A., Rosenzweig P., Patat A., and O'Hanlon J.F. Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (Amisulpride) and a classic (Haloperidol) antipsychotic. Journal of Clinical Psychopharmacology 19 (1999) 209-221
29. Reichenberg A., Rieckmann N., and Harvey P.D. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study. Journal of Abnormal Psychology 114 (2005) 363-372
30. Rey M.J., Schulz P., Costa C., Dick P., and Tissot R. Guidelines for the dosage of neuroleptics. I: chlorpromazine equivalents of orally administered neuroleptics. International Clinical Psychopharmacology 4 (1989) 95-104
31. Ridler K., Veijola J.M., Tanskanen P., Miettunen J., Chitnis X., Suckling J., Murray G.K., Haapea M., Jones P.B., Isohanni M.K., and Bullmore E.T. Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 15651-15656
32. Shamir E., Laudon M., Barak Y., Anis Y., Rotenberg V., Elizur A., and Zisapel N. Melatonin improves sleep quality of patients with chronic schizophrenia. Journal of Clinical Psychiatry 61 (2000) 373-377
33. Silverstein M.L., Mavrolefteros G., and Turnbull A. Premorbid factors in relation to motor, memory, and executive functions deficits in adult schizophrenia. Schizophrenia Research 61 (2003) 271-280
34. Spalletta G., Pasini A., De Angelis F., and Troisi A. Patients with deficit, nondeficit, and negative symptom schizophrenia: do they differ during episodes of acute psychotic decompensation?. Schizophrenia Research 24 (1997) 341-348
35. Stanley N. Actigraphy in human psychopharmacology: a review. Human Psychophamacology 18 (2003) 39-49
36. Teicher M.H. Actigraphy and motion analysis: new tools for psychiatry. Harvard Review of Psychiatry 3 (1995) 18-35
37. Teixeira L.R., Lowden A., Turte S.L., Nagai R., Moreno C.R., Latorre M.R., and Fischer F.M. Sleep and sleepiness among working and non-working high school evening students. Chronobiology International 24 (2007) 99-113
38. Van den Oord E.J., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszar J., Murrelle L., Moller H.J., Middleton L., and Muglia P. Factor structure and external validity of the PANSS revisited. Schizophrenia Research 82 (2006) 213-223
39. Whitty P., Clarke M., Browne S., McTigue O., Kamali M., Feeney L., Lane A., Kinsella A., Waddington J.L., Larkin C., and O'Callaghan E. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine 33 (2003) 1479-1484
40. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64 (2003) 663-667
41. Wulff K., Joyce E., Middleton B., Dijk D.J., and Foster R.G. The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report. Chronobiology International 23 (2006) 485-495